Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme.
about
Fatty acids as therapeutic auxiliaries for oral and parenteral formulationsCo-opting biology to deliver drugsLow density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugsTarget drug delivery system as a new scarring modulation after glaucoma filtration surgeryPreparation and characterization of a lovastatin-loaded protein-free nanostructured lipid carrier resembling high-density lipoprotein and evaluation of its targeting to foam cellsTargeted intracellular delivery of resveratrol to glioblastoma cells using apolipoprotein E-containing reconstituted HDL as a nanovehicle.Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver.The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increases in vitro drug delivery across blood-brain barrier cells.Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E.Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.Synthesis of apolipoprotein B lipoparticles to deliver hydrophobic/amphiphilic materials.Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines.Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis.Synthetic low-density lipoprotein (sLDL) selectively delivers paclitaxel to tumor with low systemic toxicity.Receptor-targeted nanocarriers for therapeutic delivery to cancer."Extremely minimally invasive": recent advances in nanotechnology research and future applications in neurosurgery.Learning from biology: synthetic lipoproteins for drug delivery.Mimicking nature's nanocarrier: synthetic low-density lipoprotein-like nanoparticles for cancer-drug delivery.Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme.Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.Lipoproteins and lipoprotein mimetics for imaging and drug delivery.Statins anticancer targeted delivery systems: re-purposing an old molecule.Cytosolic delivery of LDL nanoparticle cargo using photochemical internalization.Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier.Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents.Self-assembling peptides form nanodiscs that stabilize membrane proteins.Apolipoprotein E3-mediated cellular uptake of reconstituted high-density lipoprotein bearing core 3, 10, or 17 nm hydrophobic gold nanoparticles.Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy.Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery.Bottom up design of nanoparticles for anti-cancer diapeutics: "put the drug in the cancer's food".Low density lipoprotein modified silica nanoparticles loaded with docetaxel and thalidomide for effective chemotherapy of liver cancer.Synthesis and Development of Lipoprotein-Based Nanocarriers for Light-Activated TheranosticsLipoprotein-Based Nanoplatforms for Cancer Molecular Imaging
P2860
Q26828805-0084D0DB-C064-49E5-B59A-ACC0DDC81DFFQ34424045-0023B6E9-C64A-4913-BF50-CDB2EEAA2A56Q34800220-7BABA2D9-407D-4958-9124-2FE52F57EBB1Q35122073-171FB2CB-6586-4A2F-8910-7E5EB62EA905Q35577213-22C91A70-DF0D-4DD0-ADED-1D62BD016BC9Q35741305-3A416E75-C4A7-40B7-B687-CCF879D35613Q36148570-FB1516BD-D9B9-4928-ACD8-3A4D55D945E3Q36446501-468E0F67-A0CE-4F75-8213-2B833899B32FQ36783549-A5A9FD11-7090-40C5-94B5-203ECEE23912Q36985913-BE3D9A58-856C-43C8-9683-780BB8881019Q37098699-5451371C-D73E-433C-B6D1-0BB349508EE5Q37214592-4EDD027A-3AE7-4D09-BB08-43D393124047Q37395788-1F8EBB84-E862-4ABA-85E6-99A5EF761574Q37588319-D2FA24F2-0043-43D1-9C25-B8A2ADFE0603Q37804383-CCD720F7-3899-4688-92A2-78A461209E88Q38244857-82692937-93AC-4D34-988F-D5F7957F14D2Q38262882-B210964F-91CD-4BF7-A1B9-5DF396EB410AQ38479609-C53B5C3D-AD7A-4934-9AB1-4C47E0C3A51BQ38526550-97A3EE34-D024-4A94-A1B1-E5D9906816E1Q38548184-A7B40234-35C5-4056-9AB4-AAD3565F3C9DQ38822339-D23D7DB2-E3A0-434E-97EF-F49C1BF621BEQ39167606-74370593-EA16-4D5D-9BDB-45828821308EQ39587660-547E59DE-67CA-46FD-96EE-F6799B8EDBCAQ39819856-0463EC8C-0D06-4116-9284-A389F14A3792Q42207993-7FDF1FD8-8007-4A23-B033-1CDC44B79809Q43875369-03968DE7-C0AB-4F5F-ADE6-9B113FE1A3B9Q46024070-168486AA-BAAC-4AF7-B46D-A692B8AF23D4Q47135091-0868BC46-7F69-4BE7-97BC-37A5164E83A1Q47604132-05E0C0BD-9DA5-43E1-8788-348DE7BDAD21Q51159201-D08CCD1F-6FCE-46B9-8539-FFA749B757B0Q55192640-21493A25-2C00-42BA-84C7-76F2BB8F31F9Q59159093-4E8E8327-437C-4B8E-94C0-2E924368F23CQ59159123-4F6799EC-3D3E-4D78-A7C0-92210440E781
P2860
Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Synthetic nano-low density lip ...... e for glioblastoma multiforme.
@en
type
label
Synthetic nano-low density lip ...... e for glioblastoma multiforme.
@en
prefLabel
Synthetic nano-low density lip ...... e for glioblastoma multiforme.
@en
P2093
P1476
Synthetic nano-low density lip ...... e for glioblastoma multiforme.
@en
P2093
Eleanor A Blakely
Kathleen A Bjornstad
Mina Nikanjam
Thomas F Budinger
Trudy M Forte
P356
10.1016/J.IJPHARM.2006.07.046
P407
P577
2006-07-31T00:00:00Z